Discover recent research that sheds light on a promising therapeutic strategy for tackling prostate cancer by targeting the ...

With the clinical development of XORLO TM1 having advanced sufficiently, including completion of a pivotal program, XORTX is initiating discussions for the XRx-026 program with the US Food and Drug ...